Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology

Journal of Neuroscience Research

Volumn 70, Issue 3, 2002, Pages 514-518

  Bowen, Richard L ^a   Smith, Mark A ^b   Harris, Peggy L R ^b   Kubat, Zvezdana ^b   Martins, Ralph N ^c   Castellani, Rudolph J ^b   Perry, George ^b   Atwood, Craig S ^b  

^a Voyager Pharmaceutical Corporation   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Alzheimer's disease; Amyloid ; Estrogen; Gonadotropin; Luteinizing hormone; Neurofibrillary tangles; Neuron; Neuropathology

Indexed keywords

AMYLOID BETA PROTEIN; ESTROGEN; FOLLITROPIN; FOLLITROPIN RECEPTOR; GONADOTROPIN; GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; SEX HORMONE;

ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LUTEINIZING HORMONE BLOOD LEVEL; NERVE CELL; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; RECEPTOR DENSITY;

AGED; ALZHEIMER DISEASE; CAUSALITY; ESTROGENS; FEEDBACK; FEMALE; HIPPOCAMPUS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOHISTOCHEMISTRY; LUTEINIZING HORMONE; MALE; MIDDLE AGED; PYRAMIDAL CELLS; RECEPTORS, LH; SEX CHARACTERISTICS; TESTOSTERONE; UP-REGULATION;

EID: 0037010296     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10452     Document Type: Article

References (43)

1. Al-Hader AA, Lei ZM, Rao CN. 1997a. Novel expression of functional luteinizing hormone/chorionic gonadotropin receptors in cultured glial cells from neonatal rat brains. Biol Reprod 56:501-507.
2. Al-Hader AA, Lei ZM, Rap CV. 1997b. Neurons from fetal rat brains contain functional luteinizing hormone/chorionic gonadotropin receptors. Biol Reprod 56:1071-1076.
3. Andersson AM, Toppari J, Haavisto AM, Petersen JH, Simell T, Simell O, Skakkebaek NE. 1998. Longitudinal reproductive hormone profiles in infants: Peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab 83:675-681.
4. Asthana S, Baker LD, Craft S, Stanczyk FZ, Veith RC, Raskind MA, Plymate SR. 2001. High-dose estradiol improves cognition for women with AD: Results of a randomized study. Neurology 57:605-612.
5. Berezovska O, Xia MQ, Page K, Wasco W, Tanzi RE, Hyman BT. 1997. Developmental regulation of presenilin mRNA expression parallels notch expression. J Neuropathol Exp Neurol 56:40-44.
6. Bowen KL, Isley JP, Atkinson RL. 2000. An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol 12:351-354.
7. Boyar R, Finkelstein J, Roffwarg H, Kapen S, Weitzman E, Hellman L. 1972. Synchronization of augmented luteinizing hormone secretion with sleep during puberty. N Engl J Med 287:582-586.
8. Chakravarti S, Collins WP, Forecast JD, Newton JR, Oram DH, Studd JW. 1976. Hormonal profiles after the menopause. BMJ 2:784-787.
9. Chen HF, Jeung EB, Stephenson M, Leung PC. 1999. Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor gamma-chain messenger ribonucleic acids that are regulated by GnRH in vitro. J Clin Endocrinol Metab 84:743-750.
10. Conn PM, Smith RG, Rogers DC. 1981. Stimulation of pituitary gonadotropin release does not require internalization of gonadotropin-releasing hormone. J Biol Chem 256:1098-1100.
11. Costa O, Mulchahey JJ, Blalock JE. 1990. Structure and function of luteinizing hormone-releasing hormone (LHRH) receptors on lymphocytes. Prog NeuroEndocrinImmunol 3:55-60.
12. Couzinet B, Schaison G. 1993. The control of gonadotrophin secretion by ovarian steroids. Human Reprod 2(Suppl):97-101.
13. Goedert M, Jakes R, Crowther RA, Six J, Lubke U, Vandermeeren M, Cras P, Trojanowski JQ, Lee VM-Y. 1993. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Nat Acad Sci USA 90:5066-5070.
14. Hasen J, Boyar RM, Shapiro LR. 1980. Gonadal function in trisomy 21. Horm Res 12:345-350.
15. Hebert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois MF. 2000. Vascular dementia: Incidence and risk factors in the Canadian study of health and aging. Stroke 31:1487-1493.
16. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG. 1994. Estrogen replacement therapy in older women: Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 51:896-900.
17. Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, McCleary CA, Klein RA, Hake AM, Farlow MR. 2000. Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebocontrolled trial. Neurology 54:295-301.
18. Hogervorst E, Williams J, Budge M, Barnetson L, Combrinck M, Smith AD. 2001. Serum total testosterone is lower in men with Alzheimer's disease. Neuroendocrinol Lett 22:163-168.
19. Hsiang YH, Berkovitz GD, Bland GL, Migeon CJ, Warren AC. 1987. Gonadal function in patients with Down syndrome. Am J Med Genet 27:449-458.
20. Jorm AF, Korten AE, Henderson AS. 1987. The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatr Scand 76:465-479.
21. Kamel F, Krey LC. 1982. Gonadal steroid modulation of LHRH-stimulated LH secretion by pituitary cell cultures. Mol Cell Endocrinol 26:151-164.
22. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E. 1997. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 48:1517-1521.
23. Khachaturian ZS. 1985. Diagnosis of Alzheimer's disease. Arch Neurol 42:1097-1105.
24. Konishi I, Kuroda H, Mandai M. 1999. Review: Gonadotropins and development of ovarian cancer. Oncology 57:45-48.
25. Lei ZM, Rao CV, Kornyei JL, Licht P, Hiatt ES. 1993. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology 132:2262-2270.
26. Lopez OL, Becker JT, Kaufer DI, Hamilton RL, Sweet RA, Klunk W, DeKosky ST. 2002. Research evaluation and prospective diagnosis of dementia with Lewy bodies. Arch Neurol 59:43-46.
27. Lukacs H, Hiatt ES, Lei ZM, Rao CV. 1995. Peripheral and intracerebro-ventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats. Horm Behav 29:42-58.
28. Manly JJ, Merchant CA, Jacobs DM, Small SA, Bell K, Ferin M, Mayeux R. 2000. Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology 54:833-837.
29. Mann DMA. 1988. The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev 43:99-136.
30. McGonigal G, Thamas B, McQuade C, Starr JM, MacLennan LW, Whalley LJ. 1993. Epidemiology of Alzheimer's presenile dementia in Scotland, 1974-88. BMJ 306:680-683.
31. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486.
32. Mulnard RA. 2000, Estrogen as a treatment for Alzheimer's disease. JAMA 284:307-308.
33. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ. 2000. Estrogen replacement therapy for treatment of mild to moderate Alzheimer's disease: A randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 283:1007-1015.
34. Neaves WB, Johnson L, Porter JC, Parker CR Jr, Petty CS. 1984. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J Clin Endocrinol Metab 59:756-763.
35. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA. 2001. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60:759-767.
36. Oliver C, Holland AJ. 1986. Down's syndrome and Alzheimer's disease: A review. Psychol Med 16:307-322.
37. Schupf N, Kapell D, Nightingale B, Rodriguez A, Tycko B, Mayeux R. 1998. Earlier onset of Alzheimer's disease in men with Down syndrome. Neurology 50:991-995.
38. Seshadri S, Zornberg GL, Derby LE, Myers MW, Jick H, Drachman DA. 2001. Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. Arch Neurol 58:435-440.
39. Short RA, Bowen RL, O'Brien PC, Graff-Radford NR. 2001. Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc 76:906-909.
40. Sternberger LA. 1986. Immunocytochemistry. New York: John Wiley & Sons, Inc.
41. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R. 1996. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432.
42. Wang PN, Liao SQ, Liu RS, Liu CY, Chao HT, Lu SR, Yu HY, Wang SJ, Liu HC. 2000. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: A controlled study. Neurology 54:2061-2066.
43. Yamada T, Hattori H, Miura A, Tanabe M, Yamori Y. 2001. Prevalence of Alzheimer's disease, vascular dementia and dementia with Lewy bodies in a Japanese population. Psychiatry Clin Neurosci 55:21-25.